Sex, drugs, and funky rhythms
- 1 April 2018
- journal article
- editorial
- Published by Elsevier in Heart Rhythm
- Vol. 15 (4) , 485-486
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Dofetilide dose reductions and discontinuations in women compared with menHeart Rhythm, 2018
- A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal‐induced arrhythmiasThe Journal of Physiology, 2017
- Dofetilide induced torsade de pointes: Mechanism, risk factors and management strategiesIndian Heart Journal, 2014
- In silico Prediction of Sex-Based Differences in Human Susceptibility to Cardiac Ventricular TachyarrhythmiasFrontiers in Physiology, 2012
- Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental ValidationPLOS Computational Biology, 2011
- Gender-related differences in ion-channel and transporter subunit expression in non-diseased human heartsJournal of Molecular and Cellular Cardiology, 2010
- Gender disparity in cardiac electrophysiology: Implications for cardiac safety pharmacologyPharmacology & Therapeutics, 2010
- Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutterJournal of Interventional Cardiac Electrophysiology, 2008
- Acute effects of oestrogen on the guinea pig and humanIKrchannels and drug‐induced prolongation of cardiac repolarizationThe Journal of Physiology, 2008
- Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular DrugsJAMA, 1993